---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-001038"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:24:51.202511+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health Q2 net income down 59% to $7.2M; guidance lowered on environmental costs

## Summary
- Net sales $244.6M (+5% YoY); GAAP diluted EPS $0.18 vs $0.43 prior; adjusted diluted EPS $0.34 vs $0.37.
- Adjusted EBITDA $30.9M (+6% YoY); Animal Health segment grew 9% while Mineral Nutrition declined 8%.
- Recorded $6.6M environmental remediation cost from tentative settlement of California contamination lawsuit.
- Updated FY23 guidance: Net income lowered to $34-38M (from $39-43M); adjusted metrics unchanged.
- Free cash flow -$45M over trailing 12 months due to inventory build to mitigate supply chain risk.

## SEC filing metadata
- accession: 0001558370-23-001038
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/0001558370-23-001038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/pahc-20230208x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-001038
- JSON: https://secwatch.observer/filing/0001558370-23-001038.json
- Plain text: https://secwatch.observer/filing/0001558370-23-001038.txt

## Key facts
- Earnings Releases
  PHIBRO ANIMAL HEALTH CORP reported financial results for the fiscal quarter ended December 31, 2022.
  - Period: the fiscal quarter ended December 31, 2022
  - Result: reported results
  source text: On February 8, 2023, Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/0001558370-23-001038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
